Still betting on Nvidia? Our AI picked this stock instead; it’s up 96%+ THIS MONTH
Investing.com -- OneMedNet Corp (NASDAQ:ONMD) stock rose 3.4% premarket Monday following the company’s announcement of significant adoption by one of the world’s top five medical device companies.
The AI-powered Real-World Data (RWD) provider revealed it has secured four distinct purchase orders from the global medical device leader under an existing master services agreement. The orders focus on delivering multimodal data to accelerate innovation in medical imaging AI model development.
"Real-World Evidence can only be generated from comprehensive, multimodal data sets. OneMedNet is uniquely positioned to deliver not only advanced medical imaging data but also the full depth of patient histories and provider notes from our partners’ electronic health records," said Aaron Green, President and CEO of OneMedNet.
The company has already begun fulfilling these orders, leveraging its iRWD™ network that encompasses clinical data from over 1,750 provider sites. The master services agreement is structured as an evergreen engagement with no fixed term.
OneMedNet specializes in providing curated, de-identified datasets that help customers accelerate AI development, enhance clinical trial design, and improve healthcare outcomes at scale.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.